Advertisement

Topics

Ocular Therapeutix™, Inc. Company Profile

19:24 EDT 14th August 2018 | BioPortfolio

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed Phase 3 clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. OTX-TP (travoprost insert) is in Phase 3 clinical development for the reduction of intraocular pressure in patients with glaucoma and ocular hypertension. The Company’s earlier stage assets include OTX-TIC, a sustained release travoprost intracameral injection for the reduction in intraocular pressure in patients with glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. These injections include the development of OTX-TKI, a tyrosine kinase inhibitor (TKI), and, in collaboration with Regeneron, an extended release protein-based anti-vascular endothelial growth factor (VEGF) trap. Ocular Therapeutix's first product, ReSure® Sealant, is FDA-approved to seal corneal incisions following cataract surgery.


News Articles [166 Associated News Articles listed on BioPortfolio]

Quotidian Technical Highlights on Selected Biotech Stocks -- Ocular Therapeutix, Onconova ...

www.wallstequities.com/registration Ocular Therapeutix On Monday, shares in Bedford, Massachusettsheadquartered Ocular Therapeutix Inc. recorded a trading volume of 158,186 shares. The stock ended...

Ocular Therapeutix files third NDA for ocular pain drug

A new drug application was filed for the third time by Ocular Therapeutix for Dextenza, or dexamethasone insert, 0.4 mg to tr -More- 

Ocular Therapeutix Announces NDA Resubmission of DEXTENZA

Ocular Therapeutix (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announc...

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced th...

Ocular Therapeutix To Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, ...

Ocular Therapeutix™ to Present at the 2018 JMP Securities Life Sciences Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and condition...

Ocular Therapeutix™ to Present at the Cowen and Company 38th Annual Health Care Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditi...

Ocular's eye pain therapy accepted for FDA review

Ocular Therapeutix's resubmitted application for Dextenza, or dexamethasone insert, 0.4 mg was accepted for review by the FDA -More- 

PubMed Articles [583 Associated PubMed Articles listed on BioPortfolio]

Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.

To evaluate long-term ocular surface clinical signs and symptoms response to therapy in patients with chronic ocular GVHD.

A Study on Ocular Morbidity among Patients with Psoriasis Visiting a Tertiary Care Hospital in Karnataka, Southern India.

Psoriasis is a chronic immune-mediated disorder with predominantly dermatological manifestations and varying prevalence in different parts of the world. Data on the ocular features of this disease are...

Ocular Toxicity Profile of ST-162 and ST-168 as Novel Bifunctional MEK/PI3K Inhibitors.

ST-162 and ST-168 are small-molecule bifunctional inhibitors of MEK and PI3K signaling pathways that are being developed as novel antitumor agents. Previous small-molecule and biologic MEK inhibitors ...

Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease.

To describe changes in visual acuity in patients fit with the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) with irregular corneas compared to those with ocular surface disease, as well a...

Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy.

To assess the long-term efficacy and safety of IVIg monotherapy in patients with recalcitrant ocular cicatricial pemphigoid (OCP).

Clinical Trials [781 Associated Clinical Trials listed on BioPortfolio]

A Retrospective Study of the Effects of Ocular Acupuncture on Ocular Motor Nerve Palsy

This retrospective observational study is designed to assess the response to treatment with ocular acupuncture and its relative factors, in terms of diplopia status, ocular motility differ...

Ocular Coil Drug Delivery Comfort Trial

The Ocular Coil is intended to provide drug delivery to the ocular surface. This study will evaluate the safety and tolerability of the placebo Ocular Coil in healthy subjects.

Surveillance of Ocular Surface Flora (SURFACE)

Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteri...

The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow

Objectives: To determine LYC-001e's influences on ocular blood flow Ocular blood flow has been implicated as a parameter relevant to eye health and involved in the disease process of sever...

Ciracadian Ocular Perfusion and Ocular Blood Flow

Compare the short term effects of two IOP-lowering medications on ocular perfusion pressure, ocular blood flow, circadian IOP and blood pressure in patients with glaucoma.

Companies [67 Associated Companies listed on BioPortfolio]

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

I-Therapeutix, Inc.

More Information about "Ocular Therapeutix™, Inc." on BioPortfolio

We have published hundreds of Ocular Therapeutix™, Inc. news stories on BioPortfolio along with dozens of Ocular Therapeutix™, Inc. Clinical Trials and PubMed Articles about Ocular Therapeutix™, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ocular Therapeutix™, Inc. Companies in our database. You can also find out about relevant Ocular Therapeutix™, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...


Corporate Database Quicklinks



Searches Linking to this Company Record